Manejo de la enfermedad de Parkinson y otros trastornos del movimiento en mujeres en edad fértil: parte 2

  title={Manejo de la enfermedad de Parkinson y otros trastornos del movimiento en mujeres en edad f{\'e}rtil: parte 2},
  author={Roc{\'i}o Garc{\'i}a-Ramos and Diego Santos-Garc{\'i}a and Araceli Alonso-Canovas and M. {\'A}lvarez-Sauco and Beatriz Ruibal Ares and A. L Castruita Avila and N{\'u}ria Caballol and F{\'a}tima Carrillo and F. Escamilla Sevilla and Espinoza Freire and J.C. G{\'o}mez Esteban and I. Legarda and Lydia L{\'o}pez Manzanares and E. L{\'o}pez Vald{\'e}s and Irene Mart{\'i}nez-Torres and Mois{\'e}s Mata and I. Pare{\'e}s and Berta Pascual-Sedano and J.C. Mart{\'i}nez Castrillo and Pablo Mir},


Estrogen, progesterone, and tic severity in women with Gilles de la Tourette syndrome
It is hypothesized that menstruating women with GTS experience subjective and objective worsening of their tics and their OCD symptoms during the premenstrual period, during which both estrogen and progesterone are higher than normal.
Pregnancy in a Series of Dystonia Patients Treated with Deep Brain Stimulation: Outcomes and Management Recommendations
In this small sample, pregnancy, delivery, and breastfeeding were safe in dystonia patients treated with DBS and the presence of DBS should not be a contraindication to pregnancy.
Botulinum toxin A during pregnancy, still a debate
Another case of OT/A injection during pregnancy of a 41 year old woman with idiopathic painful cervical dystonia, who spontaneously delivered a healthy, 3400-g boy in June 2011, is reported.
Movement disorders in pregnancy.
Most of the data on the use of drugs during pregnancy, especially the dopaminergic agents, are limited to animal studies and case reports, so it is in part left to the neurologist to decide on treatment based on the individual patient, clinical judgment, and inferences fromAnimal studies and limited case reports.
Treatment of restless legs syndrome: Evidence‐based review and implications for clinical practice (Revised 2017) §
The objective of the current review was to update the previous evidence‐based medicine review of treatments for restless legs syndrome, and to highlight gaps and needs for future clinical research and studies of restless Legs syndrome.